ABOUT THE EVENT
Date: Wednesday, April 22, 2026 10–11am EDT
Event Location: Virtual
As antibody-drug conjugates (ADCs) evolve toward more complex architectures, such as bispecific and dual-payload ADCs, traditional analytical methods are increasingly challenged in accurately characterizing critical quality attributes (CQAs).
In this webinar, AsymBio expert Dr. Zhao will discuss robust analytical strategies for addressing these complexities, with key topics including drug-to-antibody ratio (DAR) determination, drug loading distribution profiling, free drug and charge variant analysis.
Attendees will gain practical insights into building fit-for-purpose analytical platforms, overcoming common method development hurdles, and ensuring reliable CQA measurement to support the advancement of next-generation ADCs.
Key Learning Objectives:
Learn analytical strategies for novel ADC characterization
Explore DAR determination and drug load distribution analysis
Understand free drug and charge variant analysis
Apply fit-for-purpose analytical approaches for reliable CQA measurement
